Showing results (3221-3230 of 27,715) with videos related to
Sort By:
Pageof 2,772
Vaccine|August 19, 2004
ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccinesTrina J Stewart, Debbie Drane, Jim Malliaros, et al.Vaccine|August 19, 2004
A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaquesMichael A Egan, Siew Yen Chong, Michael Hagen, et al.Vaccine|January 1, 1992
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis AE F Ellerbeck, J A Lewis, D Nalin, et al.Vaccine|January 1, 1992
Production of porcine parvovirus empty capsids with high immunogenic activityC Martínez, K Dalsgaard, J A López de Turiso, et al.Vaccine|January 1, 1992
Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and CP Costantino, S Viti, A Podda, et al.Vaccine|March 23, 2005
The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant propertiesPatrick Munro, Gilles Flatau, Fabienne Anjuère, et al.Vaccine|March 23, 2005
Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adultsPierre Vandepapelière, Barbara Rehermann, Marguerite Koutsoukos, et al.Vaccine|March 23, 2005
CD4+ T cell epitope affinity to MHC II influences the magnitude of CTL responses elicited by DNA epitope vaccinesDimitrios N Vatakis, Yi Ting Koh, Minnie McMillanVaccine|March 23, 2005
Vaccination with recombinant HBsAg-HBIG complex in healthy adultsDao-Zhen Xu, Ke-Lin Huang, Kai Zhao, et al.Vaccine|January 1, 1992
Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypesH Holzmann, M S Vorobyova, I P Ladyzhenskaya, et al.Pageof 2,772